News

Articles

Article “How to patent biological materials from 3D printing” for LSIPR

The article “How to patent biological materials from 3D printing,” written by our partner Priscila Kashiwabara and patent specialist Breno Souza, has been published in the “Life Sciences IP Review” magazine.

The text discusses the application of 3D printing, specifically the 3D bioprinting, in the field of medicine. The authors explore the challenges and possibilities related to the patentability of biological materials, such as tissues, cells, and parts of the human body, reproduced through 3D printing in Brazil.

A priori, animal organs and tissues are not considered eligible for protection under the Brazilian Industrial Property Law. However, the article discusses the patent possibility for biological materials due to bio-ink compositions, as well as the methods and the machinery associated. According to the authors, the composition containing cells and other ingredients is the key to secure IP protection for the “bio-ink” used to print new human tissues

Learn more here.

Back

Last related news

12 de November de 2025

The responsibility of educational institutions in preventing students from using pirated software

The academic environment is essential for shaping responsible professionals and citizens. That’s why respect for legality and intellectual property must be an The responsibility of educational institutions in preventing students from using pirated software

  • Kasznar Leonardos
  • Ler notícia

    6 de November de 2025

    Lexology Panoramic: Designs 2026 is now live

    We are pleased to share the Brazil chapter of the Designs Panoramic guide, authored by our partners Viviane Trojan, Tarso Machado & Lexology Panoramic: Designs 2026 is now live

    Ler notícia

    29 de October de 2025

    Lexology Panoramic: Pharma & Medical Device Regulation 2026

    We are pleased to share the Brazil chapter of the Pharma & Medical Device Regulation Panoramic guide, authored by our partners Claudio Lexology Panoramic: Pharma & Medical Device Regulation 2026

    Ler notícia